Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2023
Frequency of Hypoglycemia Assessed by Continuous Glucose Monitoring in Advanced CKDYasuyuki Ushiogi, Hideo Kanehara, Tamayo Kato
Diabetes Research and Clinical Practice|June 3, 2008
CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseasesMasafumi Koga, Soji Kasayama, Hideo Kanehara, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 20, 2015
Is glycated albumin useful for differential diagnosis between fulminant type 1 diabetes mellitus and acute-onset autoimmune type 1 diabetes mellitus?Masafumi Koga, Hideo Kanehara, Yukihiro Bando, et al.
Journal of Atherosclerosis and Thrombosis|May 13, 2003
Effect of cilostazol on impaired vasodilatory response of the brachial artery to ischemia in smokersKoji Oida, Kiyokazu Ebata, Hideo Kanehara, et al.
Thrombosis Research|March 6, 2003
Thrombomodulin expression by THP-1 but not by vascular endothelial cells is upregulated by pioglitazoneHideo Kanehara, Gen Tohda, Koji Oida, et al.
Journal of Diabetes Investigation|May 21, 2014
Obesity may attenuate the HbA1c-lowering effect of sitagliptin in Japanese type 2 diabetic patientsYukihiro Bando, Hideo Kanehara, Keiko Aoki, et al.
Annals of Clinical Biochemistry|August 14, 2009
Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver diseaseYukihiro Bando, Hideo Kanehara, Daisyu Toya, et al.
Endocrine Journal|July 21, 2007
Myxedema ascites with an extremely elevated CA125 Level: a case reportHideo Kanehara, Yukihiro Bando, Manabu Tomita, et al.
Diabetes Research and Clinical Practice|January 3, 2009
Characteristics of undiagnosed diabetes mellitus in a population undergoing health screening in Japan: target populations for efficient screeningYukihiro Bando, Hideo Kanehara, Keiko Aoki, et al.
Journal of Clinical & Translational Endocrinology|October 26, 2017
Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitusYukihiro Bando, Hitomi Tohyama, Keiko Aoki, et al.
Pageof 3